Literature DB >> 22245977

Thermocautery for inferior conjunctivochalasis.

Satoru Nakasato1, Riyo Uemoto, Nobuhisa Mizuki.   

Abstract

PURPOSE: To describe a thermocautery technique to treat symptomatic inferior conjunctivochalasis.
METHODS: Thirty-nine eyes of 23 patients with symptomatic inferior conjunctivochalasis were treated with thermocautery. The mean age of the patients was 78.6 ± 5.4 years (±SD) with a range of 69-89 years. Patients with symptomatic inferior conjunctivochalasis were initially treated with topical medication, and the eyes that were unresponsive underwent a ligation test. We treated those eyes in which symptoms improved or disappeared during the ligation test. The redundant bulbar conjunctival tissue was grasped with smooth forceps and cauterized with the OPTEMP variable low temperature cauterizer until the redundant conjunctival tissue was gone. The mean follow-up period was 469.5 ± 234.6 days (range, 101-823 days).
RESULTS: After the thermocautery, the symptoms disappeared in 36 of 39 eyes (92.3%) and improved in the remaining 3 eyes (7.7%). The conjunctival laxity disappeared in 36 of 39 eyes (92.3%) and improved in 3 eyes (7.7%). There were no recurrences of the conjunctival laxity during the follow-up period.
CONCLUSIONS: Thermocautery is a simple and effective treatment for symptomatic inferior conjunctivochalasis.

Entities:  

Mesh:

Year:  2012        PMID: 22245977     DOI: 10.1097/ICO.0b013e3181dc81d2

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  10 in total

Review 1.  A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain.

Authors:  Harrison Dermer; Daniella Lent-Schochet; Despoina Theotoka; Christian Paba; Abdullah A Cheema; Ryan S Kim; Anat Galor
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

2.  Restoration of Fornix Tear Reservoir in Conjunctivochalasis With Fornix Reconstruction.

Authors:  Anny M S Cheng; Han Y Yin; Rendian Chen; Sean Tighe; Hosam Sheha; Dandan Zhao; Victoria Casas; Scheffer C G Tseng
Journal:  Cornea       Date:  2016-06       Impact factor: 2.651

3.  Isotonic Glycerol and Sodium Hyaluronate Containing Artificial Tear Decreases Conjunctivochalasis after One and Three Months: A Self-Controlled, Unmasked Study.

Authors:  Huba J Kiss; János Németh
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

4.  Change in Tear Film Lipid Layer Thickness, Corneal Thickness, Volume and Topography after Superficial Cauterization for Conjunctivochalasis.

Authors:  Tommy C Y Chan; Cong Ye; Paul K F Ng; Emmy Y M Li; Hunter K L Yuen; Vishal Jhanji
Journal:  Sci Rep       Date:  2015-07-17       Impact factor: 4.379

5.  Dynamic, heterogeneous endothelial Tie2 expression and capillary blood flow during microvascular remodeling.

Authors:  Molly R Kelly-Goss; Bo Ning; Anthony C Bruce; Daniel N Tavakol; David Yi; Song Hu; Paul A Yates; Shayn M Peirce
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

6.  Near-infrared laser thermal conjunctivoplasty.

Authors:  Jianlong Yang; Rahul Chandwani; Varun Gopinatth; Tim Boyce; Stephen C Pflugfelder; David Huang; Gangjun Liu
Journal:  Sci Rep       Date:  2018-03-01       Impact factor: 4.379

7.  A Quick Surgical Treatment of Conjunctivochalasis Using Radiofrequencies.

Authors:  Alexandra Trivli; Georgios Dalianis; Chryssa Terzidou
Journal:  Healthcare (Basel)       Date:  2018-02-12

8.  Clinical characteristics of patients with conjunctivochalasis.

Authors:  Ozlem Balci
Journal:  Clin Ophthalmol       Date:  2014-08-28

9.  A New Surgical Approach for the Treatment of Conjunctivochalasis: Reduction of the Conjunctival Fold with Bipolar Electrocautery Forceps.

Authors:  Eduardo Arenas; Diana Muñoz
Journal:  ScientificWorldJournal       Date:  2016-04-21

Review 10.  Trends in conjunctivochalasis research from 1986 to 2017: A bibliometric analysis.

Authors:  Yanqing Zhao; Li Huang; Minhong Xiang; Qingsong Li; Wanhong Miao; Zhengchi Lou
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.